IL-8 is overexpressed in PPP skin biopsies compared to PV and healthy skin; this finding has been proved in a clinical setting using an anti-IL-8 monoclonal antibody that obtained a good clinical response in PPP but has failed to obtain efficacy in a phase II trial in PV43. This evidence concerns the gene CXCL8 and acquired polycythemia vera.